Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Mieulet

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Communications|October 13, 2015
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasTina Gruosso, Camille Garnier, Sophie Abelanet, et al.
The EMBO Journal|June 10, 2006
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activityDavid Shahbazian, Philippe P Roux, Virginie Mieulet, et al.
Science Signaling|August 19, 2010
TPL-2-mediated activation of MAPK downstream of TLR4 signaling is coupled to arginine availabilityVirginie Mieulet, Lijun Yan, Caroline Choisy, et al.
EMBO Molecular Medicine|March 24, 2016
Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patientsTina Gruosso, Virginie Mieulet, Melissa Cardon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2025
Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and functionDunja Capitan-Sobrino, Mailys Mouysset, Orlane Maloudi, et al.
Nature Communications|March 15, 2018
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancersAnne-Marie Givel, Yann Kieffer, Alix Scholer-Dahirel, et al.
Cell Metabolism|September 25, 2018
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian CancersGéraldine Gentric, Yann Kieffer, Virginie Mieulet, et al.
Cancers|May 14, 2022
Glycolysis Dependency as a Hallmark of <i>SF3B1</i>-Mutated CellsRaquel Vivet-Noguer, Malcy Tarin, Christine Canbezdi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Communications|October 13, 2015
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasTina Gruosso, Camille Garnier, Sophie Abelanet, et al.
The EMBO Journal|June 10, 2006
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activityDavid Shahbazian, Philippe P Roux, Virginie Mieulet, et al.
Science Signaling|August 19, 2010
TPL-2-mediated activation of MAPK downstream of TLR4 signaling is coupled to arginine availabilityVirginie Mieulet, Lijun Yan, Caroline Choisy, et al.
EMBO Molecular Medicine|March 24, 2016
Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patientsTina Gruosso, Virginie Mieulet, Melissa Cardon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2025
Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and functionDunja Capitan-Sobrino, Mailys Mouysset, Orlane Maloudi, et al.
Nature Communications|March 15, 2018
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancersAnne-Marie Givel, Yann Kieffer, Alix Scholer-Dahirel, et al.
Cell Metabolism|September 25, 2018
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian CancersGéraldine Gentric, Yann Kieffer, Virginie Mieulet, et al.
Cancers|May 14, 2022
Glycolysis Dependency as a Hallmark of <i>SF3B1</i>-Mutated CellsRaquel Vivet-Noguer, Malcy Tarin, Christine Canbezdi, et al.
Pageof 2